TORONTO, July 3 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of
medical, surgical and disability management services, today announced a
strategic change in its Board of Directors was made at the Company's annual
meeting, held last Friday, June 27. The changes bring the total number of
directors up from four to eight and add significant expertise in a variety of
healthcare related niche industries. Alegro also discussed the initiation of a
strategic review process aimed at enhancing the current business units and
"I'm very excited at the caliber of the board we now have in place. We've
added seasoned expertise in legal, business operations, health insurance,
workers compensation and laboratory medicine," said Brenda Rasmussen,
President and Chief Executive Officer of Alegro Health Corp. "The team we now
have in place is the team necessary to drive our strategic review and forward
vision to become Canada's leading health services network."
Joining Brenda Rasmussen, Bob Leshchyshen and Gilbert Sharpe on the Board
of Directors, is Stephen Goldman, founding member of Goldman Rosen LLP; Dr.
Roger Korman, Chairman and CEO of Aptilon Corporation; Dr. Robert MacMillan,
former Executive Director of Ontario's Health Insurance Division (OHIP); Mr.
Michael O'Keefe, former President and CEO of the Ontario Workers Compensation
Board; and Dr. Kenneth Pritzker, former Chief, Pathology and Laboratory
Medicine, at Mount Sinai Hospital from 1986 to 2008. In addition to these
changes, Dr. Jack Shevel, President of Global Healthcare Investment Solutions,
resigned from the Board and will concentrate solely on his relationship with
Alegro as a consultant on healthcare business and operations.
The Board of Directors first initiative will be a strategic review in
early August, primarily aimed at enhancing the current business units,
diversifying income streams within the healthcare industry and proceeding with
financing vehicles to fund strategic expansion opportunities.
About Alegro Health Corp.
Alegro Health Corp. is a leading Canadian healthcare services provider
that offers medical and consulting services to corporations and individuals.
Through the Company's subsidiaries - Don Mills Surgical Unit, Work Able
Centres, Direct Health Solutions and CanAm Research - Alegro provides a
variety of surgical procedures, disability management, third-party medical
assessments and support of drug trial administration. With a broad service
offering and the growth of the healthcare services sector, Alegro is pursuing
a vertically integrated approach and an aggressive acquisition strategy to
become Canada's leading third-party healthcare services provider. Alegro is
listed on the TSX Venture Exchange under the symbol AGO. For further
information, please visit www.alegrohealth.com.
Certain information in this press release is based on beliefs and
assumptions of the Company's senior management and information currently
available to it that may constitute forward-looking information within the
meaning of securities laws. Such statements reflect the current views of the
Company with respect to future events and are subject to certain risks and
uncertainties. Actual results, events, and performance may differ materially.
Readers are cautioned not to place undue reliance on these forward-looking
This release was prepared by management of the Company who takes full
responsibility for its contents. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or accuracy
of this news release.
For further information:
For further information: Brenda Rasmussen, President and CEO, (416)
496-6166 x-328, email@example.com; Michael Moore, Investor
Relations, (416) 815-0700 x241, firstname.lastname@example.org